Jiangsu Hengrui Medicine
600276.SS
#489
Rank
$41.70 B
Marketcap
$6.54
Share price
-1.27%
Change (1 day)
-0.35%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

P/S ratio for Jiangsu Hengrui Medicine (600276.SS)

P/S ratio as of October 2024 (TTM): 11.5

According to Jiangsu Hengrui Medicine 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.59. At the end of 2024 the company had a P/S ratio of 12.0.

P/S ratio history for Jiangsu Hengrui Medicine from 2003 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202412.0-4.63%
202312.612.78%
202211.2-11.97%
202112.7-43.33%
202022.435.94%
201916.552.47%
201810.8-24.79%
201714.455.63%
20169.25-7.92%
201510.032.97%
20147.55-10.35%
20138.4321.96%
20126.91-6.57%
20117.40-38.95%
201012.112.7%
200910.727.97%
20088.40-34.51%
200712.868.68%
20067.60135.45%
20053.2311.58%
20042.8942.01%
20032.04